Maven Securities »

Mineralys Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $726k 20k 36.29

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Citadel Advisors
FMR
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management

View all funds holding Mineralys Therapeutics